DARUNAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE

DARUNAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE was reported 2754 times

DARUNAVIR, COBICISTAT, EMTRICITABINE, AND TENOFOVIR ALAFENAMIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ASPIRATION BURSA 2 0.2857
1 CYTOMEGALOVIRUS PANCREATITIS 2 0.2000
2 CYSTIC FIBROSIS CARRIER 1 0.1429
3 NEUROENDOCRINE TUMOUR METASTATIC 1 0.1111
4 BLOOD HIV RNA 5 0.0962
5 PROCTITIS CHLAMYDIAL 1 0.0909
6 SACRAL RADICULOPATHY 1 0.0714
7 TESTICULAR OPERATION 4 0.0714
8 CORONARY OSTIAL STENOSIS 8 0.0635
9 RECTAL ATRESIA 1 0.0476
10 BONE LOSS 609 0.0405
11 SKELETAL INJURY 373 0.0360
12 BONE DENSITY DECREASED 1067 0.0340
13 BONE DEMINERALISATION 36 0.0340
14 MULTIPLE FRACTURES 529 0.0322
15 TOOTH LOSS 565 0.0272
16 PROTEIN TOTAL ABNORMAL 34 0.0261
17 CONGENITAL HIV INFECTION 1 0.0256
18 PSYCHOPATHIC PERSONALITY 2 0.0244
19 VIRAL LOAD 4 0.0231
20 HYPOSOMNIA 1 0.0217
21 PHARMACEUTICAL NOMADISM 11 0.0215
22 PRODUCT LABEL COUNTERFEIT 1 0.0204
23 BONE DENSITY ABNORMAL 75 0.0200
24 RHABDOMYOMA 1 0.0189
25 OSTEONECROSIS 608 0.0185
26 ALVEOLAR BONE RESORPTION 1 0.0169
27 OSTEOPENIA 247 0.0163
28 TOOTH INJURY 70 0.0161
29 NIPPLE SWELLING 4 0.0159
30 VIRAL LOAD INCREASED 59 0.0152
31 RENAL INJURY 426 0.0143
32 GLOMERULAR FILTRATION RATE 1 0.0137
33 B-CELL SMALL LYMPHOCYTIC LYMPHOMA 3 0.0130
34 SPONDYLITIC MYELOPATHY 1 0.0125
35 ANHEDONIA 317 0.0121
36 PALATE INJURY 1 0.0120
37 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME ASSOCIATED TUBERCULOSIS 4 0.0119
38 SOCIOECONOMIC PRECARITY 2 0.0116
39 MITOCHONDRIAL DNA MUTATION 1 0.0116
40 CONGENITAL MUSCULOSKELETAL DISORDER 1 0.0115
41 PRODUCT USE IN UNAPPROVED THERAPEUTIC ENVIRONMENT 10 0.0114
42 X-RAY LIMB ABNORMAL 1 0.0110
43 OSTEOPOROSIS 433 0.0105
44 FANCONI SYNDROME ACQUIRED 17 0.0097
45 TEETH BRITTLE 10 0.0096
46 CD4 LYMPHOCYTES ABNORMAL 2 0.0095
47 TUBEROUS SCLEROSIS COMPLEX 1 0.0095
48 GLOMERULAR FILTRATION RATE ABNORMAL 13 0.0092
49 DISSEMINATED MYCOBACTERIUM AVIUM COMPLEX INFECTION 2 0.0090
50 DEGENERATIVE BONE DISEASE 4 0.0090
51 BLOOD HIV RNA INCREASED 16 0.0088
52 FEMOROACETABULAR IMPINGEMENT 1 0.0081
53 VIROLOGIC FAILURE 42 0.0078
54 VITAMIN D DEFICIENCY 75 0.0077
55 CHRONIC KIDNEY DISEASE 578 0.0076
56 PANCREATIC DUCT DILATATION 2 0.0073
57 HUMAN IMMUNODEFICIENCY VIRUS TRANSMISSION 2 0.0072
58 PROTEIN TOTAL INCREASED 19 0.0071
59 NASAL CYST 1 0.0071
60 RENAL TUBULAR DYSFUNCTION 4 0.0071
61 AVULSION FRACTURE 2 0.0070
62 EPENDYMOMA 1 0.0069
63 TOOTH DEVELOPMENT DISORDER 1 0.0068
64 DENTAL NECROSIS 2 0.0068
65 INCLUSION BODY MYOSITIS 1 0.0067
66 ECONOMIC PROBLEM 101 0.0067
67 PLATELET AGGREGATION ABNORMAL 1 0.0066
68 BLOOD CREATININE 1 0.0065
69 MONONEURITIS 1 0.0064
70 VIRAL MUTATION IDENTIFIED 23 0.0062
71 LUMBOSACRAL RADICULOPATHY 1 0.0062
72 NEPHROPATHY 58 0.0062
73 UROBILINOGEN URINE INCREASED 1 0.0061
74 GENITALIA EXTERNAL AMBIGUOUS 1 0.0058
75 TOOTH MALFORMATION 1 0.0058
76 INFUSION SITE INJURY 1 0.0057
77 DRUG RESISTANCE MUTATION 1 0.0056
78 BODY FAT DISORDER 3 0.0055
79 CYTOMEGALOVIRUS OESOPHAGITIS 2 0.0054
80 SIGHT DISABILITY 1 0.0053
81 OSTEOMALACIA 8 0.0052
82 CD4 LYMPHOCYTES DECREASED 11 0.0051
83 FAT TISSUE DECREASED 2 0.0051
84 OROPHARYNGEAL CANCER 1 0.0048
85 HIV VIRAEMIA 1 0.0048
86 GLUCOCORTICOID DEFICIENCY 2 0.0047
87 T-LYMPHOCYTE COUNT DECREASED 3 0.0044
88 STOMA SITE REACTION 3 0.0044
89 SCHIZOPHRENIFORM DISORDER 1 0.0041
90 SLEEVE GASTRECTOMY 1 0.0041
91 INFESTATION 1 0.0039
92 FRACTURE 73 0.0039
93 CYANOSIS CENTRAL 1 0.0038
94 RENAL FAILURE 509 0.0038
95 HEART FAILURE WITH REDUCED EJECTION FRACTION 2 0.0037
96 HEPATITIS B SURFACE ANTIGEN POSITIVE 1 0.0036
97 PLATELET DYSFUNCTION 1 0.0036
98 ANAEMIA OF MALIGNANT DISEASE 1 0.0036
99 METABOLIC SURGERY 4 0.0035
100 DEVICE COMPUTER ISSUE 1 0.0033
101 BONE METABOLISM DISORDER 1 0.0033
102 CREATININE URINE INCREASED 1 0.0033
103 FOOT FRACTURE 62 0.0033
104 PARKINSONIAN GAIT 2 0.0032
105 TESTICULAR SWELLING 4 0.0032
106 ANTICOAGULATION DRUG LEVEL INCREASED 1 0.0031
107 BLOOD CREATINE PHOSPHOKINASE DECREASED 1 0.0030
108 COMMINUTED FRACTURE 1 0.0030
109 EMOTIONAL DISTRESS 353 0.0029
110 ARTERIOVENOUS FISTULA THROMBOSIS 1 0.0029
111 VIRAEMIA 4 0.0029
112 TRIGEMINAL NERVE DISORDER 1 0.0029
113 FOREARM FRACTURE 2 0.0029
114 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 3 0.0028
115 INTENSIVE CARE 4 0.0028
116 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 14 0.0028
117 PLASMABLASTIC LYMPHOMA 1 0.0028
118 SYPHILIS 2 0.0028
119 GRANDIOSITY 1 0.0027
120 TOOTH FRACTURE 30 0.0027
121 PANCREATIC ENLARGEMENT 1 0.0027
122 MEDIASTINAL DISORDER 1 0.0027
123 MULTIPLE DRUG THERAPY 2 0.0027
124 LIMB ASYMMETRY 2 0.0026
125 METASTATIC LYMPHOMA 1 0.0026
126 HAND FRACTURE 18 0.0025
127 GLOMERULAR FILTRATION RATE INCREASED 2 0.0024
128 PATHOGEN RESISTANCE 22 0.0024
129 INCORRECT PRODUCT DOSAGE FORM ADMINISTERED 1 0.0024
130 DYSLIPIDAEMIA 12 0.0024
131 HEPATITIS A 2 0.0024
132 CRANIOFACIAL FRACTURE 2 0.0023
133 HIV INFECTION 7 0.0023
134 JAW FRACTURE 5 0.0023
135 ADENOCARCINOMA GASTRIC 2 0.0022
136 CEREBRAL TOXOPLASMOSIS 2 0.0021
137 PATELLA FRACTURE 5 0.0021
138 ATTENTION DEFICIT HYPERACTIVITY DISORDER 9 0.0021
139 BONE CYST 2 0.0021
140 CHONDROLYSIS 1 0.0021
141 RADIUS FRACTURE 5 0.0021
142 GASTROINTESTINAL TOXICITY 10 0.0021
143 TYPE V HYPERLIPIDAEMIA 1 0.0021
144 GLOMERULAR FILTRATION RATE DECREASED 25 0.0020
145 STOMA SITE HAEMORRHAGE 3 0.0019
146 GENOTYPE DRUG RESISTANCE TEST POSITIVE 2 0.0019
147 ANKLE FRACTURE 30 0.0019
148 ACQUIRED IMMUNODEFICIENCY SYNDROME 1 0.0019
149 ANAL ATRESIA 1 0.0019
150 FRACTURE PAIN 1 0.0019
151 ENZYME ABNORMALITY 1 0.0019
152 MANUFACTURING PRODUCT SHIPPING ISSUE 1 0.0018
153 CORONARY ARTERY STENOSIS 9 0.0018
154 SOFT TISSUE SWELLING 1 0.0018
155 PRODUCT COUNTERFEIT 3 0.0017
156 POLYDACTYLY 2 0.0017
157 OSTEOGENESIS IMPERFECTA 1 0.0017
158 TIBIA FRACTURE 8 0.0017
159 BONE MARROW TOXICITY 2 0.0017
160 PHYSICAL PRODUCT LABEL ISSUE 2 0.0017
161 JOINT ARTHROPLASTY 3 0.0017
162 RENAL TUBULAR INJURY 2 0.0016
163 SITTING DISABILITY 1 0.0016
164 INTERVERTEBRAL DISC DEGENERATION 15 0.0016
165 LUNG CARCINOMA CELL TYPE UNSPECIFIED RECURRENT 1 0.0016
166 LIPOHYPERTROPHY 1 0.0016
167 STOMA SITE ERYTHEMA 3 0.0016
168 BLOOD CREATININE INCREASED 104 0.0016
169 BONE DISORDER 29 0.0016
170 WRIST FRACTURE 19 0.0016
171 PATHOLOGICAL FRACTURE 8 0.0016
172 CLAVICLE FRACTURE 6 0.0016
173 RENAL IMPAIRMENT 127 0.0015
174 BONE DEFORMITY 1 0.0015
175 HEPATITIS B DNA INCREASED 1 0.0015
176 INGROWN HAIR 1 0.0014
177 PERIODONTAL DISEASE 2 0.0014
178 BLOOD OESTROGEN DECREASED 1 0.0014
179 FANCONI SYNDROME 2 0.0014
180 FAT TISSUE INCREASED 2 0.0014
181 CREATININE RENAL CLEARANCE INCREASED 1 0.0013
182 CATHETER SITE RELATED REACTION 1 0.0013
183 CARDIAC INFECTION 1 0.0013
184 WRONG PRODUCT ADMINISTERED 9 0.0013
185 END STAGE RENAL DISEASE 24 0.0013
186 DEBRIDEMENT 1 0.0013
187 GASTROSTOMY 2 0.0013
188 MUSCLE DISCOMFORT 1 0.0013
189 STOMACH MASS 1 0.0013
190 TESTICULAR PAIN 4 0.0013
191 GOUTY ARTHRITIS 1 0.0013
192 PENILE HAEMORRHAGE 1 0.0012
193 SHOULDER FRACTURE 2 0.0012
194 RENAL ABSCESS 1 0.0012
195 GUTTATE PSORIASIS 1 0.0012
196 DOCUMENTED HYPERSENSITIVITY TO ADMINISTERED PRODUCT 1 0.0012
197 COVID-19 IMMUNISATION 1 0.0012
198 TWIN PREGNANCY 1 0.0012
199 HIP FRACTURE 38 0.0012
200 DEAFNESS BILATERAL 2 0.0012
201 DENTAL CARIES 13 0.0012
202 ANXIETY 334 0.0012
203 URGE INCONTINENCE 1 0.0011
204 SELF-DESTRUCTIVE BEHAVIOUR 1 0.0011
205 CATHETER SITE PRURITUS 1 0.0011
206 DRUG DIVERSION 7 0.0011
207 RIB FRACTURE 23 0.0011
208 FACIAL BONES FRACTURE 4 0.0011
209 PRODUCT OUTER PACKAGING ISSUE 1 0.0011
210 PROTEINURIA 21 0.0011
211 STOMA SITE DISCHARGE 3 0.0011
212 BONE CONTUSION 1 0.0011
213 GASTRIC OPERATION 1 0.0011
214 IMMUNE-MEDIATED MYOSITIS 3 0.0011
215 ABULIA 1 0.0011
216 CATHETER SITE SWELLING 1 0.0011
217 INJECTION SITE ULCER 1 0.0011
218 SOLAR LENTIGO 1 0.0011
219 MECHANICAL VENTILATION 2 0.0011
220 LIPOATROPHY 1 0.0011
221 PARTNER STRESS 1 0.0010
222 EXERCISE TOLERANCE DECREASED 6 0.0010
223 HUMERUS FRACTURE 5 0.0010
224 CORRECTIVE LENS USER 1 0.0010
225 SUSPECTED COUNTERFEIT PRODUCT 4 0.0010
226 ULNA FRACTURE 1 0.0010
227 MUCOSAL DISORDER 1 0.0010
228 HAEMANGIOMA OF LIVER 1 0.0010
229 LIPIDS INCREASED 2 0.0010
230 PRODUCT COATING ISSUE 1 0.0010
231 BREAST ABSCESS 1 0.0010
232 CORONAVIRUS TEST POSITIVE 1 0.0010
233 PSYCHOTIC SYMPTOM 2 0.0010
234 BONE MARROW OEDEMA 1 0.0010
235 PERTUSSIS 1 0.0010
236 SLEEP DEFICIT 2 0.0009
237 PRODUCT COMMINGLING 1 0.0009
238 HYPERTENSIVE NEPHROPATHY 1 0.0009
239 COMPRESSION FRACTURE 5 0.0009
240 HYPERPHOSPHATAEMIA 2 0.0009
241 OSTEOARTHRITIS 39 0.0009
242 CERVICAL DYSPLASIA 2 0.0009
243 HENOCH-SCHONLEIN PURPURA 2 0.0009
244 SPINAL OSTEOARTHRITIS 8 0.0009
245 NAIL GROWTH ABNORMAL 1 0.0009
246 BLOOD CREATINE INCREASED 4 0.0009
247 NEPHROSCLEROSIS 1 0.0009
248 ACUTE KIDNEY INJURY 135 0.0009
249 BLOODY DISCHARGE 1 0.0009
250 CYTOMEGALOVIRUS COLITIS 2 0.0009
251 CERVICAL VERTEBRAL FRACTURE 3 0.0009
252 PRETERM PREMATURE RUPTURE OF MEMBRANES 1 0.0008
253 ENCEPHALITIS VIRAL 1 0.0008
254 STERNAL FRACTURE 1 0.0008
255 FREEZING PHENOMENON 3 0.0008
256 FRACTURED SACRUM 1 0.0008
257 RENAL ATROPHY 1 0.0008
258 SPINAL FRACTURE 16 0.0008
259 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 7 0.0008
260 HIP ARTHROPLASTY 12 0.0008
261 CACHEXIA 4 0.0008
262 ANGINA UNSTABLE 5 0.0008
263 COUNTERFEIT PRODUCT ADMINISTERED 1 0.0008
264 WISDOM TEETH REMOVAL 1 0.0008
265 CORONAVIRUS INFECTION 5 0.0008
266 RENAL PAIN 8 0.0008
267 UPPER LIMB FRACTURE 15 0.0008
268 BODY MASS INDEX INCREASED 1 0.0007
269 GLYCOSURIA 1 0.0007
270 PRODUCT LABEL ISSUE 5 0.0007
271 INFUSION SITE RASH 1 0.0007
272 SPINAL STENOSIS 3 0.0007
273 ABSCESS LIMB 3 0.0007
274 INTERVERTEBRAL DISC DISORDER 3 0.0007
275 FIBULA FRACTURE 2 0.0007
276 URINE ANALYSIS ABNORMAL 2 0.0007
277 CORONARY ARTERY OCCLUSION 9 0.0007
278 TOOTH EXTRACTION 8 0.0006
279 YELLOW SKIN 3 0.0006
280 TRANSCRIPTION MEDICATION ERROR 1 0.0006
281 OSTEOSCLEROSIS 1 0.0006
282 LOWER LIMB FRACTURE 12 0.0006
283 LIVER ABSCESS 2 0.0006
284 SKULL FRACTURE 1 0.0006
285 CRYPTOCOCCOSIS 1 0.0006
286 METABOLIC SYNDROME 1 0.0006
287 VACCINATION FAILURE 1 0.0006
288 MEDICAL PROCEDURE 1 0.0006
289 PAIN 368 0.0006
290 BENIGN PROSTATIC HYPERPLASIA 3 0.0006
291 EMOTIONAL POVERTY 1 0.0006
292 TREATMENT NONCOMPLIANCE 31 0.0006
293 PRODUCT SIZE ISSUE 3 0.0006
294 HIP SURGERY 3 0.0006
295 OPPORTUNISTIC INFECTION 1 0.0005
296 ON AND OFF PHENOMENON 3 0.0005
297 ADENOCARCINOMA OF COLON 1 0.0005
298 LIVING IN RESIDENTIAL INSTITUTION 1 0.0005
299 SMALL INTESTINAL PERFORATION 1 0.0005
300 STENOSIS 1 0.0005
301 GUN SHOT WOUND 1 0.0005
302 FACE INJURY 2 0.0005
303 QUALITY OF LIFE DECREASED 7 0.0005
304 GINGIVAL RECESSION 1 0.0005
305 CYTOMEGALOVIRUS CHORIORETINITIS 1 0.0005
306 SEXUAL DYSFUNCTION 6 0.0005
307 BICYTOPENIA 1 0.0005
308 JOINT NOISE 1 0.0005
309 BLADDER DISORDER 5 0.0005
310 MUSCLE CONTRACTURE 1 0.0005
311 TENSION 3 0.0005
312 RENAL HAEMORRHAGE 1 0.0005
313 INJECTION SITE NECROSIS 1 0.0005
314 RENAL MASS 1 0.0005
315 HYPERPARATHYROIDISM 1 0.0005
316 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 4 0.0005
317 SPINAL COMPRESSION FRACTURE 4 0.0005
318 HEPATIC STEATOSIS 9 0.0005
319 SKIN INDURATION 1 0.0005
320 RENAL NEOPLASM 1 0.0005
321 LIPODYSTROPHY ACQUIRED 1 0.0005
322 CATHETER SITE ERYTHEMA 1 0.0005
323 LYMPHOCYTOSIS 1 0.0005
324 AMYOTROPHIC LATERAL SCLEROSIS 1 0.0005
325 ATRIOVENTRICULAR BLOCK FIRST DEGREE 2 0.0005
326 RENAL TUBULAR ACIDOSIS 1 0.0005
327 SOPOR 6 0.0005
328 SPINAL COLUMN INJURY 1 0.0004
329 ILEUS PARALYTIC 2 0.0004
330 URINARY TRACT DISORDER 2 0.0004
331 CHRONIC GASTRITIS 1 0.0004
332 RENAL COLIC 1 0.0004
333 PERIARTHRITIS 1 0.0004
334 SCAB 5 0.0004
335 NEOPLASM 5 0.0004
336 BLOOD CHOLESTEROL ABNORMAL 2 0.0004
337 METHAEMOGLOBINAEMIA 1 0.0004
338 MENOPAUSAL SYMPTOMS 1 0.0004
339 MANIA 7 0.0004
340 ESCHERICHIA BACTERAEMIA 1 0.0004
341 URINARY TRACT OBSTRUCTION 1 0.0004
342 INTRA-ABDOMINAL HAEMORRHAGE 1 0.0004
343 WEIGHT ABNORMAL 1 0.0004
344 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 20 0.0004
345 RASH VESICULAR 2 0.0004
346 SELF ESTEEM DECREASED 1 0.0004
347 DYSSTASIA 12 0.0004
348 ORAL DISORDER 3 0.0004
349 PROTEIN URINE PRESENT 2 0.0004
350 GASTROINTESTINAL TUBE INSERTION 1 0.0004
351 HYPERPARATHYROIDISM SECONDARY 1 0.0004
352 PNEUMOCYSTIS JIROVECII PNEUMONIA 4 0.0004
353 EMPHYSEMA 4 0.0004
354 SLUGGISHNESS 4 0.0004
355 BOWEL MOVEMENT IRREGULARITY 3 0.0004
356 SHOCK 9 0.0004
357 FEMORAL NECK FRACTURE 2 0.0004
358 MENOPAUSE 1 0.0004
359 FOETAL DEATH 2 0.0004
360 PERIORBITAL OEDEMA 2 0.0004
361 MALABSORPTION 2 0.0004
362 RADICULOPATHY 1 0.0004
363 RENAL CYST 3 0.0004
364 NASAL DISORDER 1 0.0004
365 BONE PAIN 22 0.0004
366 SHOULDER ARTHROPLASTY 1 0.0004
367 PRODUCT RESIDUE PRESENT 2 0.0004
368 DECREASED ACTIVITY 4 0.0004
369 STRESS FRACTURE 2 0.0004
370 GAMBLING DISORDER 1 0.0004
371 CHONDROPATHY 1 0.0004
372 LIP BLISTER 1 0.0004
373 ENDOTRACHEAL INTUBATION 1 0.0004
374 RENAL TUBULAR DISORDER 1 0.0004
375 MULTIPLE ORGAN DYSFUNCTION SYNDROME 10 0.0004
376 NEPHROLITHIASIS 16 0.0003
377 VOMITING PROJECTILE 1 0.0003
378 PERIPHERAL SENSORY NEUROPATHY 2 0.0003
379 ACUTE MYOCARDIAL INFARCTION 10 0.0003
380 BRADYKINESIA 2 0.0003
381 HAEMARTHROSIS 3 0.0003
382 HEPATITIS B 2 0.0003
383 CENTRAL VENOUS CATHETERISATION 1 0.0003
384 HEPATITIS C 4 0.0003
385 BONE MARROW DISORDER 1 0.0003
386 EYE INJURY 1 0.0003
387 EXOSTOSIS 3 0.0003
388 FIBROSIS 1 0.0003
389 FEMUR FRACTURE 10 0.0003
390 SCOLIOSIS 2 0.0003
391 RENAL DISORDER 15 0.0003
392 INTERVERTEBRAL DISC PROTRUSION 7 0.0003
393 HEPATITIS B REACTIVATION 1 0.0003
394 ERECTILE DYSFUNCTION 8 0.0003
395 LOOSE TOOTH 1 0.0003
396 DIZZINESS POSTURAL 3 0.0003
397 HEPATITIS ACUTE 2 0.0003
398 FACET JOINT SYNDROME 1 0.0003
399 HEPATIC NEOPLASM 1 0.0003
400 OEDEMA MOUTH 1 0.0003
401 RENAL TUBULAR NECROSIS 3 0.0003
402 BREAST ENLARGEMENT 1 0.0003
403 PRODUCT PREPARATION ISSUE 2 0.0003
404 INJECTION SITE INFECTION 1 0.0003
405 DEAFNESS NEUROSENSORY 1 0.0003
406 NEAR DEATH EXPERIENCE 1 0.0003
407 LYME DISEASE 1 0.0003
408 ANXIETY DISORDER 1 0.0003
409 POTENTIATING DRUG INTERACTION 1 0.0003
410 TOXIC SKIN ERUPTION 3 0.0003
411 INTENTIONAL SELF-INJURY 6 0.0003
412 WOUND COMPLICATION 1 0.0003
413 EXPOSURE DURING PREGNANCY 18 0.0003
414 BLOOD CREATININE ABNORMAL 1 0.0003
415 NIGHTMARE 10 0.0003
416 HYPOPNOEA 1 0.0003
417 HOSPITALISATION 44 0.0003
418 NEUROTOXICITY 5 0.0003
419 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
420 HAEMORRHAGIC DIATHESIS 1 0.0003
421 DEPRESSION 63 0.0003
422 RENAL TRANSPLANT 1 0.0003
423 PRODUCT DISPENSING ERROR 6 0.0003
424 RASH PUSTULAR 2 0.0003
425 MAJOR DEPRESSION 2 0.0003
426 GAIT INABILITY 9 0.0003
427 DRUG INTERACTION 42 0.0003
428 WEIGHT INCREASED 59 0.0003
429 LOW DENSITY LIPOPROTEIN INCREASED 2 0.0003
430 REHABILITATION THERAPY 1 0.0003
431 PELVIC FRACTURE 2 0.0003
432 PROSTATOMEGALY 1 0.0003
433 OESOPHAGEAL PAIN 1 0.0003
434 DISABILITY 5 0.0003
435 MUSCLE RIGIDITY 3 0.0003
436 MUSCLE HAEMORRHAGE 1 0.0002
437 INTRACRANIAL ANEURYSM 1 0.0002
438 ORGAN FAILURE 1 0.0002
439 STENT PLACEMENT 2 0.0002
440 PRODUCT PHYSICAL ISSUE 5 0.0002
441 FRUSTRATION TOLERANCE DECREASED 2 0.0002
442 SPINAL FUSION SURGERY 1 0.0002
443 HYPERURICAEMIA 1 0.0002
444 LEG AMPUTATION 1 0.0002
445 CYST 3 0.0002
446 DYSPNOEA EXERTIONAL 9 0.0002
447 ONYCHOMADESIS 1 0.0002
448 EATING DISORDER 5 0.0002
449 CARDIAC FAILURE CHRONIC 1 0.0002
450 PULMONARY TUBERCULOSIS 1 0.0002
451 TENSION HEADACHE 1 0.0002
452 HORDEOLUM 1 0.0002
453 OCULAR ICTERUS 1 0.0002
454 STAPHYLOCOCCAL BACTERAEMIA 1 0.0002
455 BONE CANCER 1 0.0002
456 SARS-COV-2 TEST POSITIVE 3 0.0002
457 PHYSICAL DISABILITY 1 0.0002
458 GOUT 4 0.0002
459 MYOSITIS 2 0.0002
460 HEART RATE IRREGULAR 5 0.0002
461 URINE ABNORMALITY 1 0.0002
462 LUMBAR VERTEBRAL FRACTURE 1 0.0002
463 NEPHROGENIC ANAEMIA 1 0.0002
464 RENAL FUNCTION TEST ABNORMAL 1 0.0002
465 ERYTHEMA MULTIFORME 2 0.0002
466 GASTROINTESTINAL DISORDER 19 0.0002
467 RECALLED PRODUCT ADMINISTERED 2 0.0002
468 GAIT DISTURBANCE 40 0.0002
469 MOBILITY DECREASED 15 0.0002
470 LIMB OPERATION 1 0.0002
471 HYPERCHOLESTEROLAEMIA 2 0.0002
472 HERNIA 4 0.0002
473 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
474 RENAL CELL CARCINOMA 1 0.0002
475 HEPATOMEGALY 2 0.0002
476 PANCREATIC DISORDER 1 0.0002
477 FEEDING DISORDER 4 0.0002
478 PRODUCT COLOUR ISSUE 1 0.0002
479 DRUG RESISTANCE 5 0.0002
480 NERVOUS SYSTEM DISORDER 6 0.0002
481 ARTHRITIS 15 0.0002
482 CATATONIA 1 0.0002
483 PRODUCT USE COMPLAINT 3 0.0002
484 JOINT DISLOCATION 2 0.0002
485 JOINT INJURY 4 0.0002
486 INJECTION SITE DISCHARGE 1 0.0002
487 BIPOLAR DISORDER 2 0.0002
488 NONSPECIFIC REACTION 1 0.0002
489 ASTHENOPIA 1 0.0002
490 TOOTH DISORDER 4 0.0002
491 NECROSIS 1 0.0002
492 INTERMENSTRUAL BLEEDING 1 0.0002
493 MALNUTRITION 2 0.0002
494 THERAPEUTIC RESPONSE UNEXPECTED 8 0.0002
495 PREMATURE LABOUR 1 0.0002
496 CHOLECYSTITIS ACUTE 1 0.0002
497 CORONARY ARTERY BYPASS 1 0.0002
498 METABOLIC DISORDER 1 0.0002
499 BLOOD CHOLESTEROL INCREASED 8 0.0002
500 HYPERTRIGLYCERIDAEMIA 1 0.0002
501 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
502 URINE ODOUR ABNORMAL 1 0.0002
503 HYPERCHLORHYDRIA 1 0.0002
504 ENERGY INCREASED 1 0.0002
505 LABORATORY TEST ABNORMAL 5 0.0002
506 RHABDOMYOLYSIS 7 0.0002
507 POLLAKIURIA 7 0.0002
508 HYPERLIPIDAEMIA 2 0.0002
509 POLYNEUROPATHY 2 0.0002
510 ENDOPHTHALMITIS 1 0.0002
511 OSTEOMYELITIS 3 0.0002
512 APHASIA 5 0.0002
513 INJECTION SITE VESICLES 1 0.0002
514 CONTRAINDICATED PRODUCT ADMINISTERED 5 0.0002
515 MENTAL IMPAIRMENT 4 0.0002
516 ADRENAL INSUFFICIENCY 2 0.0002
517 NOCTURIA 2 0.0002
518 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0002
519 RASH 71 0.0002
520 ABDOMINAL DISTENSION 17 0.0002
521 ABNORMAL WEIGHT GAIN 2 0.0002
522 GASTROOESOPHAGEAL REFLUX DISEASE 13 0.0002
523 BACTERIAL INFECTION 3 0.0002
524 INFUSION SITE EXTRAVASATION 1 0.0002
525 SECRETION DISCHARGE 2 0.0002
526 DERMATITIS ALLERGIC 2 0.0002
527 MULTIPLE INJURIES 1 0.0002
528 BLEPHAROSPASM 1 0.0002
529 MUSCLE ATROPHY 2 0.0002
530 LIVER DISORDER 7 0.0002
531 MYDRIASIS 2 0.0002
532 NIGHT SWEATS 5 0.0002
533 TENDON DISORDER 1 0.0002
534 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
535 POLYP 1 0.0002
536 SOMNAMBULISM 1 0.0002
537 ADVERSE EVENT 14 0.0002
538 ORAL CANDIDIASIS 2 0.0002
539 ABORTION SPONTANEOUS 6 0.0001
540 CHOLECYSTITIS CHRONIC 1 0.0001
541 TYPE 2 DIABETES MELLITUS 5 0.0001
542 TASTE DISORDER 3 0.0001
543 RASH PRURITIC 8 0.0001
544 GENERAL PHYSICAL CONDITION ABNORMAL 1 0.0001
545 GINGIVAL BLEEDING 2 0.0001
546 ACUTE HEPATIC FAILURE 2 0.0001
547 BLOOD TESTOSTERONE DECREASED 1 0.0001
548 HAEMATURIA 5 0.0001
549 NEPHROTIC SYNDROME 1 0.0001
550 JOINT EFFUSION 1 0.0001
551 HAIR GROWTH ABNORMAL 1 0.0001
552 HYPERTRANSAMINASAEMIA 1 0.0001
553 FORMICATION 1 0.0001
554 HUNGER 2 0.0001
555 DERMATITIS 3 0.0001
556 MASS 2 0.0001
557 DIALYSIS 2 0.0001
558 THERMAL BURN 1 0.0001
559 OROPHARYNGEAL PAIN 13 0.0001
560 IMPAIRED WORK ABILITY 3 0.0001
561 LIVER FUNCTION TEST INCREASED 3 0.0001
562 PRODUCT DOSE OMISSION ISSUE 41 0.0001
563 HYPERTHYROIDISM 2 0.0001
564 APATHY 2 0.0001
565 NEUROPATHY PERIPHERAL 13 0.0001
566 SURGERY 8 0.0001
567 MOUTH HAEMORRHAGE 1 0.0001
568 FOETAL EXPOSURE DURING PREGNANCY 11 0.0001
569 STEVENS-JOHNSON SYNDROME 3 0.0001
570 CHROMATURIA 3 0.0001
571 WEIGHT DECREASED 37 0.0001
572 HYPERTHERMIA 1 0.0001
573 DEVICE PHYSICAL PROPERTY ISSUE 1 0.0001
574 THYROID DISORDER 2 0.0001
575 GYNAECOMASTIA 4 0.0001
576 CONGENITAL ANOMALY 1 0.0001
577 MULTIPLE ALLERGIES 1 0.0001
578 TORSADE DE POINTES 1 0.0001
579 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
580 AFFECTIVE DISORDER 1 0.0001
581 DRUG SCREEN POSITIVE 1 0.0001
582 FURUNCLE 1 0.0001
583 NASAL DISCOMFORT 1 0.0001
584 TRICUSPID VALVE INCOMPETENCE 1 0.0001
585 LOW BIRTH WEIGHT BABY 1 0.0001
586 PREMATURE DELIVERY 2 0.0001
587 SCIATICA 2 0.0001
588 SENSORY DISTURBANCE 2 0.0001
589 MUSCLE DISORDER 1 0.0001
590 DYSKINESIA 5 0.0001
591 BACK DISORDER 2 0.0001
592 STAPHYLOCOCCAL INFECTION 4 0.0001
593 EMBOLISM 1 0.0001
594 ARTHRALGIA 50 0.0001
595 HAEMODIALYSIS 1 0.0001
596 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
597 CANDIDA INFECTION 2 0.0001
598 FACIAL PARALYSIS 1 0.0001
599 VITAMIN D DECREASED 1 0.0001
600 GASTRIC DISORDER 4 0.0001
601 SKIN HYPERPIGMENTATION 1 0.0001
602 ANURIA 1 0.0001
603 DYSPHAGIA 11 0.0001
604 HYSTERECTOMY 1 0.0001
605 PYELONEPHRITIS 1 0.0001
606 JOINT STIFFNESS 3 0.0001
607 NAIL DISORDER 1 0.0001
608 GROIN PAIN 1 0.0001
609 HEAD DISCOMFORT 2 0.0001
610 ADVERSE DRUG REACTION 10 0.0001
611 LOSS OF LIBIDO 1 0.0001
612 OROPHARYNGEAL DISCOMFORT 1 0.0001
613 PERIPHERAL SWELLING 17 0.0001
614 HYPERGLYCAEMIA 4 0.0001
615 DYSURIA 4 0.0001
616 ABNORMAL DREAMS 3 0.0001
617 DIARRHOEA 70 0.0001
618 IRON DEFICIENCY ANAEMIA 1 0.0001
619 PERSONALITY CHANGE 1 0.0001
620 THINKING ABNORMAL 2 0.0001
621 MIDDLE INSOMNIA 2 0.0001
622 COGNITIVE DISORDER 5 0.0001
623 APPENDICITIS 1 0.0001
624 SWELLING 10 0.0001
625 TUBULOINTERSTITIAL NEPHRITIS 2 0.0001
626 FLANK PAIN 1 0.0001
627 FLATULENCE 6 0.0001
628 SPINAL DISORDER 1 0.0001
629 AFFECT LABILITY 1 0.0001
630 ATELECTASIS 1 0.0001
631 LIVER FUNCTION TEST ABNORMAL 3 0.0001
632 HEPATIC ENZYME INCREASED 7 0.0001
633 HAEMORRHOIDS 2 0.0001
634 NASAL CONGESTION 6 0.0001
635 KIDNEY INFECTION 2 0.0001
636 THERAPY CHANGE 1 0.0001
637 KNEE OPERATION 1 0.0001
638 HOSPICE CARE 1 0.0001
639 SINUS DISORDER 2 0.0001
640 INABILITY TO AFFORD MEDICATION 1 0.0001
641 RESPIRATORY DISORDER 3 0.0001
642 THERAPEUTIC RESPONSE DECREASED 6 0.0001
643 PRODUCT ADMINISTRATION ERROR 2 0.0001
644 MOTOR DYSFUNCTION 1 0.0001
645 EUPHORIC MOOD 1 0.0001
646 DEATH 84 0.0001
647 INITIAL INSOMNIA 1 0.0001
648 MYOCARDIAL INFARCTION 17 0.0001
649 TEMPERATURE INTOLERANCE 1 0.0001
650 HYPERBILIRUBINAEMIA 1 0.0001
651 DRUG-INDUCED LIVER INJURY 3 0.0001
652 WEIGHT FLUCTUATION 1 0.0001
653 PRODUCT ODOUR ABNORMAL 1 0.0001
654 FOLLICULITIS 1 0.0001
655 GENERAL PHYSICAL HEALTH DETERIORATION 11 0.0001
656 KNEE ARTHROPLASTY 2 0.0001
657 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
658 SCRATCH 1 0.0001
659 HALLUCINATION, VISUAL 2 0.0001
660 BACK PAIN 22 0.0001
661 PANCREATITIS 5 0.0001
662 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
663 INSOMNIA 25 0.0001
664 POOR QUALITY SLEEP 2 0.0001
665 PRODUCT PRESCRIBING ISSUE 2 0.0001
666 INTENTIONAL PRODUCT MISUSE 8 0.0001
667 ASPIRATION 1 0.0001
668 FOOT DEFORMITY 1 0.0001
669 MEDICATION ERROR 5 0.0001
670 TRANSAMINASES INCREASED 2 0.0001
671 NERVE INJURY 1 0.0001
672 NEOPLASM MALIGNANT 6 0.0001
673 OCULAR DISCOMFORT 1 0.0001
674 BLOOD CALCIUM DECREASED 1 0.0001
675 STATUS EPILEPTICUS 1 0.0001
676 MITRAL VALVE INCOMPETENCE 1 0.0001
677 MUSCULAR WEAKNESS 10 0.0001
678 PRODUCT AVAILABILITY ISSUE 2 0.0001
679 ASTHENIA 33 0.0001
680 HAEMORRHAGE 9 0.0001
681 CAESAREAN SECTION 1 0.0001
682 SPINAL PAIN 1 0.0001
683 LYMPHADENOPATHY 3 0.0001
684 TREATMENT FAILURE 7 0.0001
685 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 6 0.0001
686 NEUROLEPTIC MALIGNANT SYNDROME 1 0.0001
687 PRODUCT PRESCRIBING ERROR 2 0.0001
688 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 17 0.0001
689 ACCIDENT 1 0.0001
690 FATIGUE 65 0.0001
691 CRYING 3 0.0001
692 SCHIZOPHRENIA 1 0.0001
693 HYPERCALCAEMIA 1 0.0001
694 CHEST PAIN 15 0.0001
695 HYPERSENSITIVITY 15 0.0001
696 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
697 ILEUS 1 0.0001
698 PRODUCT COMPLAINT 2 0.0001
699 INFUSION SITE PAIN 1 0.0001
700 RASH GENERALISED 2 0.0001
701 INJECTION SITE INDURATION 1 0.0001
702 NAUSEA 61 0.0001
703 CHILLS 9 0.0001
704 IMMUNE SYSTEM DISORDER 1 0.0001
705 TOOTH INFECTION 1 0.0001
706 DISORIENTATION 3 0.0001
707 DEPRESSED MOOD 4 0.0001
708 HYPERTENSION 16 0.0001
709 ADVERSE REACTION 1 0.0001
710 JOINT RANGE OF MOTION DECREASED 1 0.0001
711 DISTURBANCE IN ATTENTION 4 0.0001
712 BLOOD BILIRUBIN INCREASED 2 0.0001
713 LIMB INJURY 2 0.0001
714 ANAEMIA 14 0.0001
715 ABDOMINAL PAIN UPPER 15 0.0001
716 DRUG ABUSE 6 0.0001
717 CARDIO-RESPIRATORY ARREST 3 0.0001
718 URTICARIA 12 0.0001
719 SLEEP DISORDER 5 0.0001
720 PAIN IN JAW 2 0.0001
721 PRURITUS 27 0.0001
722 HYPERSOMNIA 2 0.0001
723 LETHARGY 4 0.0001
724 EYE IRRITATION 4 0.0001
725 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
726 PRODUCT USE ISSUE 13 0.0001
727 DEVICE DISLOCATION 3 0.0001
728 MENTAL DISORDER 3 0.0001
729 FLUID OVERLOAD 1 0.0001
730 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0001
731 ASCITES 2 0.0001
732 ANGIOEDEMA 3 0.0001
733 BRONCHITIS 5 0.0001
734 DEHYDRATION 9 0.0001
735 HYPOAESTHESIA 10 0.0001
736 HALLUCINATION 5 0.0001
737 LACRIMATION INCREASED 2 0.0001
738 SUICIDAL IDEATION 6 0.0001
739 INSURANCE ISSUE 1 0.0001
740 TINNITUS 3 0.0001
741 LYMPHOMA 1 0.0001
742 MUSCULOSKELETAL CHEST PAIN 1 0.0001
743 TENDONITIS 1 0.0001
744 DELUSION 1 0.0001
745 BLOOD GLUCOSE INCREASED 12 0.0001
746 HEAD INJURY 2 0.0001
747 FALL 21 0.0001
748 HALLUCINATION, AUDITORY 1 0.0001
749 ULCER 1 0.0001
750 SEPSIS 7 0.0001
751 MOOD SWINGS 2 0.0001
752 MOVEMENT DISORDER 2 0.0001
753 VOMITING 29 0.0001
754 SEIZURE 7 0.0001
755 DRUG LEVEL INCREASED 1 0.0001
756 ABDOMINAL PAIN 14 0.0001
757 EXPIRED PRODUCT ADMINISTERED 2 0.0001
758 VIRAL INFECTION 2 0.0001
759 COAGULOPATHY 1 0.0001
760 LEUKOPENIA 3 0.0001
761 SKIN DISORDER 2 0.0001
762 URINARY RETENTION 2 0.0001
763 BLOOD UREA INCREASED 1 0.0001
764 MYALGIA 10 0.0001
765 PNEUMONIA 19 0.0001
766 MUSCULOSKELETAL DISCOMFORT 1 0.0001
767 PARANOIA 1 0.0001
768 OEDEMA PERIPHERAL 7 0.0001
769 MUSCULOSKELETAL PAIN 3 0.0001
770 PRODUCT STORAGE ERROR 5 0.0001
771 MUSCULOSKELETAL STIFFNESS 5 0.0001
772 INJURY 4 0.0001
773 DRUG ERUPTION 1 0.0001
774 DIZZINESS 28 0.0001
775 GALLBLADDER DISORDER 1 0.0001
776 THIRST 1 0.0001
777 OEDEMA 3 0.0001
778 TOOTHACHE 1 0.0001
779 ACCIDENTAL OVERDOSE 2 0.0001
780 FEELING ABNORMAL 13 0.0001
781 BLOOD GLUCOSE ABNORMAL 1 0.0001
782 ARTHROPATHY 3 0.0001
783 CONJUNCTIVITIS 1 0.0001
784 OFF LABEL USE 47 0.0001
785 THROMBOCYTOPENIA 6 0.0001
786 HEPATIC FUNCTION ABNORMAL 2 0.0001
787 HEPATIC CIRRHOSIS 1 0.0001
788 EYE PAIN 3 0.0001
789 PHOTOPHOBIA 1 0.0001
790 HOT FLUSH 4 0.0001
791 BLOOD URINE PRESENT 1 0.0001
792 GASTRIC ULCER 1 0.0001
793 DIABETES MELLITUS 4 0.0001
794 HERPES ZOSTER 3 0.0001
795 PULMONARY FIBROSIS 1 0.0001
796 ACUTE RESPIRATORY FAILURE 1 0.0001
797 EAR PAIN 1 0.0001
798 PAIN IN EXTREMITY 15 0.0001
799 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 9 0.0000
800 THROMBOSIS 4 0.0000
801 FULL BLOOD COUNT DECREASED 1 0.0000
802 CONFUSIONAL STATE 8 0.0000
803 BONE MARROW FAILURE 1 0.0000
804 DISCOMFORT 3 0.0000
805 BLINDNESS 2 0.0000
806 BODY TEMPERATURE INCREASED 1 0.0000
807 FEELING HOT 3 0.0000
808 ILLNESS 5 0.0000
809 HEADACHE 30 0.0000
810 ROAD TRAFFIC ACCIDENT 2 0.0000
811 ABDOMINAL DISCOMFORT 8 0.0000
812 MOUTH ULCERATION 1 0.0000
813 IRRITABLE BOWEL SYNDROME 1 0.0000
814 HYPOACUSIS 2 0.0000
815 DRUG INEFFECTIVE 61 0.0000
816 BALANCE DISORDER 4 0.0000
817 PRURITUS GENERALISED 1 0.0000
818 WHITE BLOOD CELL COUNT DECREASED 5 0.0000
819 FAECES DISCOLOURED 1 0.0000
820 MELAENA 1 0.0000
821 RASH MACULO-PAPULAR 1 0.0000
822 HEPATOTOXICITY 1 0.0000
823 MATERNAL EXPOSURE DURING PREGNANCY 4 0.0000
824 COLITIS ULCERATIVE 2 0.0000
825 SNEEZING 1 0.0000
826 PARAESTHESIA 7 0.0000
827 SKIN DISCOLOURATION 2 0.0000
828 MUSCLE TWITCHING 1 0.0000
829 PYREXIA 15 0.0000
830 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 2 0.0000
831 BURNING SENSATION 3 0.0000
832 PALPITATIONS 5 0.0000
833 ARRHYTHMIA 2 0.0000
834 RENAL CANCER 2 0.0000
835 MIGRAINE 4 0.0000
836 NEURALGIA 1 0.0000
837 UNDERDOSE 3 0.0000
838 ATRIAL FIBRILLATION 4 0.0000
839 LIVER INJURY 1 0.0000
840 ALOPECIA 8 0.0000
841 DYSPEPSIA 4 0.0000
842 EPISTAXIS 3 0.0000
843 AGEUSIA 1 0.0000
844 HEPATITIS 1 0.0000
845 THERAPY CESSATION 2 0.0000
846 ERYTHEMA 8 0.0000
847 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1 0.0000
848 SKIN ULCER 1 0.0000
849 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
850 EAR INFECTION 1 0.0000
851 THROAT TIGHTNESS 1 0.0000
852 DEVICE DELIVERY SYSTEM ISSUE 1 0.0000
853 SKIN LESION 1 0.0000
854 PRODUCT USE IN UNAPPROVED INDICATION 9 0.0000
855 DIVERTICULITIS 1 0.0000
856 MENTAL STATUS CHANGES 1 0.0000
857 NECK PAIN 2 0.0000
858 CEREBROVASCULAR ACCIDENT 6 0.0000
859 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
860 INTENTIONAL DOSE OMISSION 1 0.0000
861 RED BLOOD CELL COUNT DECREASED 1 0.0000
862 ANGINA PECTORIS 1 0.0000
863 SOMNOLENCE 7 0.0000
864 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
865 DYSPHONIA 2 0.0000
866 PSYCHOTIC DISORDER 1 0.0000
867 OESOPHAGEAL CARCINOMA 1 0.0000
868 BLOOD POTASSIUM DECREASED 1 0.0000
869 PREMATURE BABY 1 0.0000
870 STOMATITIS 2 0.0000
871 VERTIGO 2 0.0000
872 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
873 EMOTIONAL DISORDER 1 0.0000
874 CONSTIPATION 7 0.0000
875 SWOLLEN TONGUE 1 0.0000
876 MALAISE 14 0.0000
877 DYSPNOEA 18 0.0000
878 CYSTITIS 1 0.0000
879 INTENTIONAL OVERDOSE 2 0.0000
880 CONTUSION 3 0.0000
881 HYPERHIDROSIS 4 0.0000
882 RHINORRHOEA 2 0.0000
883 DEEP VEIN THROMBOSIS 2 0.0000
884 AMNESIA 2 0.0000
885 PRODUCT DOSE OMISSION 2 0.0000
886 CHOLELITHIASIS 1 0.0000
887 IMPAIRED HEALING 1 0.0000
888 EYE DISORDER 1 0.0000
889 TREMOR 5 0.0000
890 LIP SWELLING 1 0.0000
891 EYE PRURITUS 1 0.0000
892 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
893 HYPERKALAEMIA 1 0.0000
894 PLATELET COUNT DECREASED 3 0.0000
895 THERAPY INTERRUPTED 2 0.0000
896 INFLUENZA 3 0.0000
897 COLITIS 1 0.0000
898 INCORRECT DOSE ADMINISTERED 6 0.0000
899 DECREASED APPETITE 6 0.0000
900 PLASMA CELL MYELOMA 1 0.0000
901 DEPRESSED LEVEL OF CONSCIOUSNESS 1 0.0000
902 ABNORMAL BEHAVIOUR 1 0.0000
903 INJECTION SITE BRUISING 2 0.0000
904 PROSTATE CANCER 2 0.0000
905 JOINT SWELLING 3 0.0000
906 EXTRA DOSE ADMINISTERED 1 0.0000
907 DRY MOUTH 2 0.0000
908 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
909 SKIN EXFOLIATION 2 0.0000
910 URINARY TRACT INFECTION 4 0.0000
911 OVERDOSE 5 0.0000
912 VAGINAL HAEMORRHAGE 1 0.0000
913 COVID-19 4 0.0000
914 TACHYCARDIA 2 0.0000
915 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
916 THROAT IRRITATION 1 0.0000
917 THERAPY NON-RESPONDER 1 0.0000
918 VISION BLURRED 3 0.0000
919 MEMORY IMPAIRMENT 3 0.0000
920 SKIN IRRITATION 1 0.0000
921 HYPOKALAEMIA 1 0.0000
922 UPPER RESPIRATORY TRACT INFECTION 1 0.0000
923 COUGH 6 0.0000
924 PULMONARY EMBOLISM 2 0.0000
925 DISEASE RECURRENCE 1 0.0000
926 RASH ERYTHEMATOUS 1 0.0000
927 INFECTION 3 0.0000
928 AGGRESSION 1 0.0000
929 CELLULITIS 1 0.0000
930 CONDITION AGGRAVATED 6 0.0000
931 FLUID RETENTION 1 0.0000
932 INJECTION SITE PAIN 6 0.0000
933 CHEST DISCOMFORT 2 0.0000
934 HAEMOGLOBIN DECREASED 2 0.0000
935 NERVOUSNESS 1 0.0000
936 ECZEMA 1 0.0000
937 DERMATITIS ATOPIC 1 0.0000
938 HAEMATOCHEZIA 1 0.0000
939 PANCYTOPENIA 1 0.0000
940 BLISTER 1 0.0000
941 PRODUCT SUBSTITUTION ISSUE 1 0.0000
942 WHEEZING 1 0.0000
943 SUICIDE ATTEMPT 1 0.0000
944 MUSCLE SPASMS 3 0.0000
945 NASOPHARYNGITIS 3 0.0000
946 SWELLING FACE 1 0.0000
947 INFUSION RELATED REACTION 1 0.0000
948 NEUTROPENIA 2 0.0000
949 SKIN BURNING SENSATION 1 0.0000
950 RESPIRATORY FAILURE 1 0.0000
951 DYSGEUSIA 1 0.0000
952 UNEVALUABLE EVENT 1 0.0000
953 ACNE 1 0.0000
954 INJECTION SITE SWELLING 1 0.0000
955 INJECTION SITE HAEMORRHAGE 1 0.0000
956 CARDIAC FAILURE 1 0.0000
957 INFLUENZA LIKE ILLNESS 1 0.0000
958 CARDIAC ARREST 1 0.0000
959 COMPLETED SUICIDE 1 0.0000
960 DRUG WITHDRAWAL SYNDROME 1 0.0000
961 NO ADVERSE EVENT 2 0.0000
962 BREAST CANCER 1 0.0000
963 CARDIAC DISORDER 1 0.0000
964 DRUG INTOLERANCE 1 0.0000
965 HEART RATE INCREASED 1 0.0000
966 SYNCOPE 1 0.0000
967 HYPOTENSION 2 0.0000
968 SINUSITIS 1 0.0000
969 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
970 DISEASE PROGRESSION 1 0.0000
971 INJECTION SITE ERYTHEMA 1 0.0000
972 LOSS OF CONSCIOUSNESS 1 0.0000
973 PSORIASIS 1 0.0000
974 DRY SKIN 1 0.0000
975 PRODUCT QUALITY ISSUE 1 0.0000
976 BLOOD PRESSURE INCREASED 1 0.0000
977 TOXICITY TO VARIOUS AGENTS 1 0.0000